BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11705103)

  • 1. Ibogaine: a review.
    Alper KR
    Alkaloids Chem Biol; 2001; 56():1-38. PubMed ID: 11705103
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibogaine in the treatment of heroin withdrawal.
    Mash DC; Kovera CA; Pablo J; Tyndale R; Ervin FR; Kamlet JD; Hearn WL
    Alkaloids Chem Biol; 2001; 56():155-71. PubMed ID: 11705106
    [No Abstract]   [Full Text] [Related]  

  • 3. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.
    Vastag B
    Science; 2005 Apr; 308(5720):345-6. PubMed ID: 15831735
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of the effects of rewarding drugs by ibogaine.
    Parker LA; Siegel S
    Alkaloids Chem Biol; 2001; 56():211-25. PubMed ID: 11705109
    [No Abstract]   [Full Text] [Related]  

  • 7. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
    Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 9. A preliminary investigation of ibogaine: case reports and recommendations for further study.
    Sheppard SG
    J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute opioid withdrawal with ibogaine.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Am J Addict; 1999; 8(3):234-42. PubMed ID: 10506904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of memory retrieval by the "anti-addictive" alkaloid, ibogaine.
    Popik P
    Life Sci; 1996; 59(24):PL379-85. PubMed ID: 8950313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents.
    Mash DC; Ameer B; Prou D; Howes JF; Maillet EL
    J Psychopharmacol; 2016 Jul; 30(7):688-97. PubMed ID: 27044509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.
    Cappendijk SL; Fekkes D; Dzoljic MR
    Behav Brain Res; 1994 Nov; 65(1):117-9. PubMed ID: 7880450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibogaine in acute opioid withdrawal. An open label case series.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Ann N Y Acad Sci; 2000; 909():257-9. PubMed ID: 10911935
    [No Abstract]   [Full Text] [Related]  

  • 16. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.
    Glick SD; Maisonneuve IM; Visker KE; Fritz KA; Bandarage UK; Kuehne ME
    Psychopharmacology (Berl); 1998 Oct; 139(3):274-80. PubMed ID: 9784085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
    Luz M; Mash DC
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
    [No Abstract]   [Full Text] [Related]  

  • 18. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
    Mash DC
    Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
    Brown TK; Alper K
    Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibogaine may help drug addicts live the 'never again'.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):580, 582. PubMed ID: 16909175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.